Deadlines Approach for Fall 2021 Applications to UNC Asheville; Chemistry First Day is Feb. 6

three students walking on campus
January 11, 2021

The Jan. 15 early decision deadline for admission to UNC Asheville’s Class of 2025 is fast approaching, and applicants who know UNC Asheville is their first choice are encouraged to get their applications in. Regular admission applications are due on Feb. 1.

UNC Asheville offers a hands-on, inspiring, and personalized education. It is a rare institution that offers students a chance to partner directly with their professors on original and relevant research and creative projects, often interdisciplinary in nature – providing this ‘private university experience’ at a very affordable public university cost.

Early decision is a binding commitment and UNC Asheville recommends that applicants file the online federal FAFSA form using school code 002907, so the University can provide financial aid information for those applicants who are accepted. Applicants for early decision can expect notification of a decision on Feb. 1; that same date also is the deadline for regular decision applications.

Prospective students can apply via the College Foundation of North Carolina application, the Common App, or via at, which also is the place for more information about UNC Asheville, and its virtual and in-person campus tours.

Chemistry First Day is Feb. 6

Prospective students interested in Chemistry can register now for Chemistry First Day on Feb. 6. Chemistry First Day – a virtual event from 10 a.m.-noon – provides a chance to meet students and faculty in the Department of Chemistry and Biochemistry at UNC Asheville, explore the research and teaching laboratories, learn about the admissions process and financial aid including the NSF SSTEM Chemistry Scholars scholarship program, and take a virtual walking tour of campus.

To register, visit or email Amanda Wolfe, associate professor of medicinal chemistry and leader of UNC Asheville’s Wolfe Laboratory, working on the discovery and development of novel small molecule antibiotic therapies, at